APA (7th ed.) Citation

LM, T., K, L., D, V., CS, F., & JB, S. (2024). Molecular Engineering of Interleukin-2 for Enhanced Therapeutic Activity in Autoimmune Diseases. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 38(2), 227. https://doi.org/10.1007/s40259-023-00635-0

Chicago Style (17th ed.) Citation

LM, Tomasovic, Liu K, VanDyke D, Fabilane CS, and Spangler JB. "Molecular Engineering of Interleukin-2 for Enhanced Therapeutic Activity in Autoimmune Diseases." BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy 38, no. 2 (2024): 227. https://doi.org/10.1007/s40259-023-00635-0.

MLA (9th ed.) Citation

LM, Tomasovic, et al. "Molecular Engineering of Interleukin-2 for Enhanced Therapeutic Activity in Autoimmune Diseases." BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, vol. 38, no. 2, 2024, p. 227, https://doi.org/10.1007/s40259-023-00635-0.